Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study
- 19 November 2025
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 232, 116109
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare (MOHW111-TDU-B-221-114007)
- Ministry of Health and Welfare (MOHW114-TDU-B-221-144007)
- Ministry of Health and Welfare (MOHW113-TDU-B-221-134007)
- Ministry of Health and Welfare (MOHW112-TDU-B-221-124007)
- Kaohsiung Medical University Chung Ho Memorial Hospital (KMUH111-1R04)
- Kaohsiung Medical University Chung Ho Memorial Hospital (KMUH112-2R09)
- Kaohsiung Medical University (113002)
- Kaohsiung Medical University (KMU-MOST 111-2314-B-037-069-MY2)
- Kaohsiung Medical University (KMU-NSTC 112-2635-B-037-001-MY2)
- Taichung Veterans General Hospital (TCVGH-1123301C)
- Taichung Veterans General Hospital (VTA113-V1-1-2)
- Taichung Veterans General Hospital (TCVGH-1133301C)
- Taichung Veterans General Hospital (VTA112-V1-3-3)
- Health and Welfare Data Science Center
- National Science and Technology Council (NSTC 112-2314-B-075A-010-MY3)
This publication has 32 references indexed in Scilit:
- Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort studyeClinicalMedicine, 2023
- Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registryHepatology International, 2023
- Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis CJAMA Internal Medicine, 2023
- Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antiviralsHepatology Communications, 2022
- Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Clinical Gastroenterology and Hepatology, 2022
- Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in TaiwanJournal of the Formosan Medical Association, 2022
- 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsJournal of the Formosan Medical Association, 2020
- Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantationJournal of Hepatology, 2017
- Impact of Sustained Virologic Response with Direct‐Acting Antiviral Treatment on Mortality in Patients with Advanced Liver DiseaseHepatology, 2017
- Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antiviralsJournal of Hepatology, 2017